STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway

References

• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22. doi:10.1038/nrc2982.
   PubMed Web of Science ®Google Scholar
• Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236. doi:10.3322/caac.20121.
   PubMed Web of Science ®Google Scholar
• Beenken SW, Krontiras H, Maddox WA, Peters GE, Soong S, Urist MM. T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection. Head Neck. 1999;21:124–130. doi:10.1002/(ISSN)1097-0347.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004;40:433–439. doi:10.1016/j.oraloncology.2003.09.013.
   PubMed Web of Science ®Google Scholar
• Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67–76. doi:10.1016/j.tripleo.2005.07.038.
   PubMed Web of Science ®Google Scholar
• Singh SK, Pal Bhadra M, Girschick HJ, Bhadra U. MicroRNAs–micro in size but macro in function. FEBS J. 2008;275:4929–4944. doi:10.1111/j.1742-4658.2008.06624.x.
   PubMed Web of Science ®Google Scholar
• Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12. doi:10.1016/j.ydbio.2006.08.028.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Reviews Genet. 2014;15:7–21. doi:10.1038/nrg3606.
   PubMed Web of Science ®Google Scholar
• Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, Colnot S, Godard C, Terris B, Jammes H, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A. 2008;105:12417–12422. doi:10.1073/pnas.0801540105.
   PubMed Web of Science ®Google Scholar
• Gomes CC, Gomez RS. MicroRNA and oral cancer: future perspectives. Oral Oncol. 2008;44:910–914. doi:10.1016/j.oraloncology.2008.01.002.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–269. doi:10.1038/nrc1840.
   PubMed Web of Science ®Google Scholar
• Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68:2094–2105. doi:10.1158/0008-5472.CAN-07-5194.
   PubMed Web of Science ®Google Scholar
• Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46:204–208. doi:10.1016/j.oraloncology.2009.12.005.
   PubMed Web of Science ®Google Scholar
• Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R, Gilbert RW, et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer. 2010;9:238. doi:10.1186/1476-4598-9-254.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7:761–766. doi:10.3892/mmr.2012.1254.
   PubMed Web of Science ®Google Scholar
• Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:89–95. doi:10.1016/j.oooo.2013.09.007.
   PubMed Web of Science ®Google Scholar
• Jia LF, Wei SB, Gan YH, Guo Y, Gong K, Mitchelson K, Cheng J, Yu G-Y. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer. 2014;135:2282–2293. doi:10.1002/ijc.28667.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Li Y, Guan B, Wang Z, Peng D, Chen Z, He A, He S, Gong Y, Li X, et al. Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2. Oncotarget. 2017;8:76656–76665. doi:10.18632/oncotarget.20795.
   PubMedGoogle Scholar
• Zhang G, An X, Zhao H, Zhang Q, Zhao H. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer. Biomed Pharmacother. 2017;98:594–599. doi:10.1016/j.biopha.2017.12.080.
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhuang P, Song W, Duan S, Xu Q, Peng M, Zhou J. Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma. Mol Med Rep. 2017;16:4694–4700. doi:10.3892/mmr.2017.7175.
   PubMed Web of Science ®Google Scholar
• Qi P, Lin WR, Zhang M, Huang D, Ni SJ, Zhu XL, Bai Q-M, Sheng W-Q, Du X, Zhou X-Y. E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition. Cancer Manag Res. 2018;10:2563–2571. doi:10.2147/CMAR.S171652.
   PubMed Web of Science ®Google Scholar
• Dong H, Wang W, Mo S, Chen R, Zou K, Han J, Zhang F, Hu J. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. J Exp Clin Cancer Res. 2018;37:202. doi:10.1186/s13046-018-0875-3.
   PubMed Web of Science ®Google Scholar
• Sheng L, Wu J, Gong X, Dong D, Sun X. SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo. Gene. 2018;668:140–145. doi:10.1016/j.gene.2018.05.065.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao Y, Jiang X, Zhong X, Wang Z, Li C, Kang P, Leng K, Ji D, Li Z, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J Exp Clin Cancer Res. 2018;37:81. doi:10.1186/s13046-018-0747-x.
   PubMed Web of Science ®Google Scholar
• Wang Y, Luo TB, Liu L, Cui ZQ. LncRNA LINC00311 Promotes the Proliferation and Differentiation of Osteoclasts in Osteoporotic Rats Through the Notch Signaling Pathway by Targeting DLL3. Cell Physiol Biochem. 2018;47:2291–2306. doi:10.1159/000491539.
   PubMed Web of Science ®Google Scholar
• Wang X, Yan Y, Zhang C, Wei W, Ai X, Pang Y, Bian Y. Upregulation of lncRNA PlncRNA-1 indicates the poor prognosis and promotes glioma progression by activation of Notch signal pathway. Biomed Pharmacother. 2018;103:216–221. doi:10.1016/j.biopha.2018.03.150.
   PubMed Web of Science ®Google Scholar
• Gao K, Ji Z, She K, Yang Q, Shao L. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway. Biomed Pharmacother. 2017;87:555–560. doi:10.1016/j.biopha.2017.01.014.
   PubMed Web of Science ®Google Scholar
• Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012;3:219. doi:10.3389/fgene.2012.00219.
   PubMedGoogle Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–361. doi:10.1016/j.tcb.2011.04.001.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma H, Zhang D, Xie S, Wang W, Li Q, Lin Z, Wang Y. LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis. 2018;9:742. doi:10.1038/s41419-018-0793-5.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang LL, Sun KX, Liu Y, Guan X, Zong ZH, Zhao Y. LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway. Cell Physiol Biochem. 2018;47:1578–1588. doi:10.1159/000490931.
   PubMed Web of Science ®Google Scholar
• Chang YT, Lin TP, Tang JT, Campbell M, Luo YL, Lu SY, Yang C-P, Cheng T-Y, Chang C-H, Liu -T-T, et al. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer. Cancer Lett. 2018;433:43–52. doi:10.1016/j.canlet.2018.06.029.
   PubMed Web of Science ®Google Scholar
• Li E, Zhao Z, Ma B, Zhang J. Long noncoding RNA HOTAIR promotes the proliferation and metastasis of osteosarcoma cells through the AKT/mTOR signaling pathway. Exp Ther Med. 2017;14:5321–5328. doi:10.3892/etm.2017.5248.
   PubMed Web of Science ®Google Scholar
• Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, Wu D-S, Fang Z-Y, Bao Y, Jiang -M-M, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16:111. doi:10.1186/s12943-017-0681-0.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xiong Y, Tang F, Bian Y, Chen Y, Zhang F. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/beta-catenin signaling pathway. Biomed Pharmacother. 2017;96:877–883. doi:10.1016/j.biopha.2017.10.033.
   PubMed Web of Science ®Google Scholar
• Zhao H, Hou W, Tao J, Zhao Y, Wan G, Ma C, Xu H. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/beta-catenin signaling pathway. Am J Transl Res. 2016;8:3503–3512.
   PubMed Web of Science ®Google Scholar
• Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett. 2015;369:20–27. doi:10.1016/j.canlet.2015.07.048.
   PubMed Web of Science ®Google Scholar
• Guilmeau S. Notch signaling and intestinal cancer. Adv Exp Med Biol. 2012;727:272–288. doi:10.1007/978-1-4614-0899-4_21.
   PubMed Web of Science ®Google Scholar
• Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60:885–890. doi:10.1016/j.jhep.2013.11.028.
   PubMed Web of Science ®Google Scholar
• Brzozowa-Zasada M, Piecuch A, Dittfeld A, Mielanczyk L, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J, Wojnicz R. Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn). 2016;20:267–272. doi:10.5114/wo.2016.61845.
   PubMed Web of Science ®Google Scholar